| abstract |
Dibenzylamine compounds and derivatives, pharmaceutical compositions containing such compounds and use of such compounds to increase certain levels of plasma lipids, including cholesterol associated with high density lipoproteins and to reduce plasma levels of other lipids, such as cholesterol- LDL and triglycerides and, therefore, to treat diseases that are exacerbated by low levels of HDL-cholesterol and / or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans. |